FDA Targets Baxter Pumps for Recall

On Sept. 25, the FDA warned that previously recalled Baxter Healthcare pumps could cause serious injury or death if used by patients.
    Baxter had issued a recall of 66 Colleague brand infusion pumps in mid-August after the company discovered falsified repair and testing documents connected with the devices. The pumps are used in hospitals and nursing homes to deliver medication directly to the blood stream. Baxter said critical device repairs may not actually have been performed.
    The agency classified the action as a Class One recall, meaning patients who use the devices could be seriously injured or die. Baxter previously said a malfunction with a device could lead to electrical shock or interruption of therapy.